300942 易瑞生物
2025/06 - 中期
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资96,970-3.69%100,690145,179195,75821,944
投资性房地产0--0005,250
固定资产501,68538.16%363,11157,10283,98652,628
在建工程70,901-64.51%199,793356,626190,86751,341
无形资产38,272-2.47%39,24341,39342,40042,600
商誉0--0000
其他非流动资产10,097272.17%2,71318,37095,02681,113
717,9261.75%705,550618,669608,036254,876

流动资产
货币资金397,21735.38%293,399481,749247,451342,211
应收账款89,929-4.39%94,05976,14883,87897,052
存货52,71230.38%40,43031,461100,60893,859
其他流动资产162,372-49.84%323,728148,312242,482364,522
702,228-6.57%751,616737,670674,419897,644

流动负债
短期借款0--0000
应付票据0--0000
应付帐款57,880-1.50%58,76277,35265,10755,658
其他流动负债51,595-44.64%93,19559,575134,676100,968
109,476-27.96%151,958136,927199,784156,626
流动资产净值592,753-1.15%599,658600,743474,636741,018
资产总额减流动负债1,310,6790.42%1,305,2081,219,4121,082,672995,894

非流动负债
长期借款163,9410.44%163,218100,32956,3200
应付债券273,8064.04%263,169245,45200
其他非流动负债7,511-12.45%8,57924,90361,65149,314
445,2592.37%434,966370,684117,97149,314

总权益
    实收股本401,3180.00%401,317400,860400,860400,860
    储备项目463,075-0.99%467,689448,134564,031543,903
股东权益864,393-0.53%869,005848,994964,891944,763
非控股权益1,028-16.90%1,237(266)(190)1,817